Justices protect generic drugmaker from patent infringement liability
In a unanimous ruling, Justice Jackson said drugmakers weren’t violating the law by truthfully describing a generic drug as equivalent to a brand-name competitor.
Original Source
Read the full article at Courthousenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.